Department of Oncology, Breast Cancer Institute, Cancer Hospital/Cancer Institute, Institutes of Biomedical Science, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai, 200032, People's Republic of China.
J Cancer Res Clin Oncol. 2010 Oct;136(10):1545-56. doi: 10.1007/s00432-010-0812-0. Epub 2010 Feb 14.
Distant metastasis represents the major lethal cause of breast cancer. To understand the molecular mechanisms of breast cancer metastasis and identify markers with metastatic potential, we established a highly metastatic variant of parental MDA-MB-231 cells (MDA-MB-231HM). Using two-dimensional electrophoresis (2-DE), we performed a proteomic comparison of the two kinds of cells. As much as 51 protein spots were differentially expressed between the selected variant and its parental counterpart in at least 3 experiments. Ten unique proteins were identified using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry (MS), liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS), and database searching software. Among them, nine proteins were up-regulated in MDA-MB-231HM cells, including Macrophage-capping protein (CapG), Galectin-1, Chloride intracellular channel protein 1, Endoplasmic reticulum protein ERp29 precursor, Stathmin-1 (STMN1), Isoform 1 of uridine-cytidine kinase 2(UCK2), Rho GDP-dissociation inhibitor 2 (ARHGDIB), isocitrate dehydrogenase [NADP] cytoplasmic (IDH1), and N-myc downstream regulated gene 1 (NDRG1) protein. Only transgelin-2 was down-regulated. Differential expression was confirmed for three proteins including CapG, STMN1, and transgelin-2 by Western blotting analysis. Transgelin-2 was chosen for further verification by immunohistochemistry. The results suggested that 2-DE would be an efficient way to screen the proteins responsible for specific biological function. Furthermore, the findings imply that different proteins may be involved in the metastatic process in breast carcinomas.
远处转移是乳腺癌的主要致死原因。为了了解乳腺癌转移的分子机制并鉴定具有转移潜能的标志物,我们建立了一个高度转移性的亲本 MDA-MB-231 细胞(MDA-MB-231HM)的变体。通过二维电泳(2-DE),我们对两种细胞进行了蛋白质组比较。在至少 3 次实验中,选择的变体与其亲本对照之间有多达 51 个蛋白斑点差异表达。使用基质辅助激光解吸/电离飞行时间(MALDI-TOF)质谱(MS)、液相色谱-电喷雾电离串联质谱(LC-ESI-MS/MS)和数据库搜索软件鉴定了 10 个独特的蛋白质。其中,9 个蛋白在 MDA-MB-231HM 细胞中上调,包括巨噬细胞封顶蛋白(CapG)、半乳糖凝集素-1、氯离子细胞内通道蛋白 1、内质网蛋白 ERp29 前体、Stathmin-1(STMN1)、尿苷-胞嘧啶激酶 2 的同工型 1(UCK2)、Rho GDP 解离抑制剂 2(ARHGDIB)、异柠檬酸脱氢酶[NADP]细胞质(IDH1)和 N- MYC 下游调节基因 1(NDRG1)蛋白。只有转胶蛋白-2 下调。通过 Western blot 分析对 CapG、STMN1 和转胶蛋白-2 三种蛋白的差异表达进行了确认。通过免疫组织化学进一步验证了转胶蛋白-2。结果表明,2-DE 将是筛选负责特定生物学功能的蛋白质的有效方法。此外,研究结果表明,不同的蛋白质可能参与乳腺癌的转移过程。